These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8175820)

  • 1. Direct modulation of osteoblastic activity with estrogen.
    Majeska RJ; Ryaby JT; Einhorn TA
    J Bone Joint Surg Am; 1994 May; 76(5):713-21. PubMed ID: 8175820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive interaction between 17 beta-Estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone.
    Rao LG; Kung Sutherland MS; Muzaffar SA; Wylie JN; McBroom RJ; Murray TM
    Osteoporos Int; 1996; 6(2):111-9. PubMed ID: 8704348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents.
    Heath JK; Atkinson SJ; Meikle MC; Reynolds JJ
    Biochim Biophys Acta; 1984 Nov; 802(1):151-4. PubMed ID: 6091772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1.
    Takuwa Y; Ohse C; Wang EA; Wozney JM; Yamashita K
    Biochem Biophys Res Commun; 1991 Jan; 174(1):96-101. PubMed ID: 1989624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization of osteoblastic MC3T3-E1 cells.
    Kim KW; Suh SJ; Lee TK; Ha KT; Kim JK; Kim KH; Kim DI; Jeon JH; Moon TC; Kim CH
    J Ethnopharmacol; 2008 Jan; 115(1):42-9. PubMed ID: 17997241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones.
    Ernst M; Heath JK; Rodan GA
    Endocrinology; 1989 Aug; 125(2):825-33. PubMed ID: 2752978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells.
    Iu MF; Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
    J Bone Miner Metab; 2005; 23(6):450-5. PubMed ID: 16261451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
    J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal-induced physiological modulations in human female osteoblastic cell line SaSO2.
    Somjen D; Katzburg S; Gigi R; Dolkart O; Sharon O; Salai M; Stern N
    J Steroid Biochem Mol Biol; 2013 May; 135():67-70. PubMed ID: 23333933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
    Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
    J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of parathyroid hormone and interleukin-1 alpha in osteoblastic MC3T3-E1 cells: interaction with beta-alanyl-L-histidinato zinc.
    Yamaguchi M; Hashizume M
    Peptides; 1994; 15(4):633-6. PubMed ID: 7937338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Mar; 196(1-2):137-45. PubMed ID: 15036763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
    Jeong JC; Lee JW; Yoon CH; Kim HM; Kim CH
    Toxicol In Vitro; 2004 Dec; 18(6):829-34. PubMed ID: 15465649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells.
    Park CK; Ishimi Y; Ohmura M; Yamaguchi M; Ikegami S
    J Nutr Sci Vitaminol (Tokyo); 1997 Jun; 43(3):281-96. PubMed ID: 9268918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice.
    Plant A; Tobias JH
    J Cell Biochem; 2001; 82(4):683-91. PubMed ID: 11500946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 is produced by osteoblasts and induces bone resorption.
    Ishimi Y; Miyaura C; Jin CH; Akatsu T; Abe E; Nakamura Y; Yamaguchi A; Yoshiki S; Matsuda T; Hirano T
    J Immunol; 1990 Nov; 145(10):3297-303. PubMed ID: 2121824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 22-oxacalcitriol on bone metabolism in vitro: comparison with calcitriol--effects of 22-oxacalcitriol on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kano J; Chihara K
    Eur J Endocrinol; 1995 Nov; 133(5):618-25. PubMed ID: 7581994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.
    Yokose S; Ishizuya T; Ikeda T; Nakamura T; Tsurukami H; Kawasaki K; Suda T; Yoshiki S; Yamaguchi A
    Endocrinology; 1996 Feb; 137(2):469-78. PubMed ID: 8593791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption.
    Stern PH; Alvares K
    J Cell Biochem; 2014 Nov; 115(11):2033-8. PubMed ID: 25042887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.